|
⚲
|
| Keyboard |
| Lees-Rolfe Garth
✚
|
|
|---|---|
| CIK # | 0002017374 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002017374] | |
| 4 | [0002017374] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lees-Rolfe Garth | |
| Ludwig Enterprises Inc | |
| Inhibikase Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-21 | Grant | 90,000 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-21 | Disposed to issuer | 5,834 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-21 | Grant | 5,834 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-21 | Disposed to issuer | 90,000 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 432,853 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 470,861 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 235,383 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (right to buy) · derivative
|
2024-04-01 | Grant | 90,000 | $0.00 |